Constantine Davides
Stock Analyst at JMP Securities
(1.08)
# 3,797
Out of 5,008 analysts
108
Total ratings
30.61%
Success rate
-15.76%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $37.91 | +26.62% | 1 | Sep 18, 2025 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $33 → $22 | $19.40 | +13.40% | 11 | Aug 12, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $14 → $20 | $17.95 | +11.42% | 9 | Aug 11, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $36 → $38 | $27.11 | +40.17% | 6 | Jul 31, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $110.64 | +35.57% | 4 | Jul 16, 2025 | |
| EVH Evolent Health | Reiterates: Market Outperform | $13 | $8.12 | +60.10% | 10 | Jun 20, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $16.50 | - | 2 | Jun 18, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $110 → $117 | $88.50 | +32.20% | 5 | Jun 4, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $12.93 | - | 3 | May 6, 2025 | |
| PRVA Privia Health Group | Reiterates: Market Outperform | $29 | $24.02 | +20.73% | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.06 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $89.77 | +25.88% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $16.90 | +53.85% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $186.97 | +32.64% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $26.89 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.12 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.00 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.42 | +269.72% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.81 | +15,351.17% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $24.64 | -39.12% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $17.20 | +30.81% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.60 | +136.11% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.53 | +815.03% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $4.03 | +8,833.00% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $2.59 | +124,996.53% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.81 | +4,828.53% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.65 | +823.08% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $2.01 | +39,701.00% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $2.76 | +180,334.78% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.97 | +8,694.62% | 2 | Sep 23, 2022 |
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $37.91
Upside: +26.62%
AMN Healthcare Services
Aug 12, 2025
Maintains: Market Outperform
Price Target: $33 → $22
Current: $19.40
Upside: +13.40%
OptimizeRx
Aug 11, 2025
Maintains: Market Outperform
Price Target: $14 → $20
Current: $17.95
Upside: +11.42%
Option Care Health
Jul 31, 2025
Maintains: Market Outperform
Price Target: $36 → $38
Current: $27.11
Upside: +40.17%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $110.64
Upside: +35.57%
Evolent Health
Jun 20, 2025
Reiterates: Market Outperform
Price Target: $13
Current: $8.12
Upside: +60.10%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $16.50
Upside: -
HealthEquity
Jun 4, 2025
Maintains: Market Outperform
Price Target: $110 → $117
Current: $88.50
Upside: +32.20%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.93
Upside: -
Privia Health Group
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $29
Current: $24.02
Upside: +20.73%
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $1.06
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $89.77
Upside: +25.88%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $16.90
Upside: +53.85%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $186.97
Upside: +32.64%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $26.89
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.12
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $20.00
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.42
Upside: +269.72%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.81
Upside: +15,351.17%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $24.64
Upside: -39.12%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $17.20
Upside: +30.81%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.60
Upside: +136.11%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.53
Upside: +815.03%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $4.03
Upside: +8,833.00%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $2.59
Upside: +124,996.53%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.81
Upside: +4,828.53%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.65
Upside: +823.08%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $2.01
Upside: +39,701.00%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $2.76
Upside: +180,334.78%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.97
Upside: +8,694.62%